Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastasis From Malignant Tumor of Prostate”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT07414940
What this trial is testing

ACTinium in Castrate-RESistant Prostate Cancer After LUTEtium

Who this might be right for
Metastatic Castration-resistant Prostate CancerMetastatic Prostate CancerProstate Cancer
University College, London 60
Not applicableStudy completedNCT02376296
What this trial is testing

Observational Study of Docetaxel Exposure in Metastatic Prostate Cancer Patients

Who this might be right for
Prostate Cancer
Saladax Biomedical, Inc. 35
Testing effectiveness (Phase 2)Study completedNCT03338790
What this trial is testing

An Investigational Immunotherapy Study of Nivolumab in Combination With Rucaparib, Docetaxel, or Enzalutamide in Metastatic Castration-resistant Prostate Cancer

Who this might be right for
Prostate Cancer
Bristol-Myers Squibb 292
Large-scale testing (Phase 3)Looking for participantsNCT03678025
What this trial is testing

Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer

Who this might be right for
Castration Levels of TestosteroneMetastatic Prostatic AdenocarcinomaStage IV Prostate Cancer AJCC v8+2 more
SWOG Cancer Research Network 1,273
Early research (Phase 1)Study completedNCT01414296
What this trial is testing

Extended Study of Prostate-specific Membrane Antigen Antibody-Drug Conjugate in Subjects With Prostate Cancer

Who this might be right for
Prostate Cancer
Progenics Pharmaceuticals, Inc. 10
Testing effectiveness (Phase 2)Study completedNCT04028388
What this trial is testing

ModraDoc006/r vs Docetaxel IV in Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer MetastaticCastration-resistant Prostate Cancer
Modra Pharmaceuticals 135
Testing effectiveness (Phase 2)Study completedNCT03418324
What this trial is testing

Study of TRC105 With Abiraterone and With Enzalutamide in Prostate Cancer Patients Progressing on Therapy

Who this might be right for
Prostate Cancer
Cedars-Sinai Medical Center 11
Testing effectiveness (Phase 2)Study completedNCT00195039
What this trial is testing

Treatment With Radiolabeled Monoclonal Antibody HuJ591-GS (177Lu-J591) in Patients With Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
Weill Medical College of Cornell University 47
Not applicableUnknownNCT03934164
What this trial is testing

Molecular Stratification Profiling Protocol in Metastatic Castration Resistant Prostate Cancer (mCRPC) - MAESTRO

Who this might be right for
Metastatic Prostate CancerCastration-resistant Prostate Cancer
Institute of Cancer Research, United Kingdom 600
Early research (Phase 1)Study completedNCT00113984
What this trial is testing

Vaccine and Antibody Treatment of Prostate Cancer

Who this might be right for
Prostatic Neoplasms
National Cancer Institute (NCI) 30
Large-scale testing (Phase 3)Study completedNCT00436839
What this trial is testing

Taxotere Prostate Cancer New Indication Registration Trial in China

Who this might be right for
Prostatic Neoplasms
Sanofi 228
Testing effectiveness (Phase 2)Study completedNCT02107391
What this trial is testing

Phase II Study of DCVAC/PCa Added to Hormone Therapy for Men With Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
SOTIO a.s. 63
Large-scale testing (Phase 3)Study completedNCT00104715
What this trial is testing

Hormone Therapy and Docetaxel or Hormone Therapy Alone in Treating Patients With Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
UNICANCER 385
Not applicableLooking for participantsNCT05582772
What this trial is testing

TOward a comPrehensive Supportive Care Intervention for Older Men With Metastatic Prostate Cancer

Who this might be right for
Metastatic Prostate Cancer
University Health Network, Toronto 168
Large-scale testing (Phase 3)Ended earlyNCT03327662
What this trial is testing

Utilising CTC Counts to Optimize Systemic Therapy of Metastatic Prostate Cancer

Who this might be right for
Adenocarcinoma of the Prostate
Institute of Cancer Research, United Kingdom 12
Large-scale testing (Phase 3)Ended earlyNCT00003682
What this trial is testing

Methylprednisolone With or Without Doxorubicin in Treating Patients With Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
UNICANCER 160
Testing effectiveness (Phase 2)WithdrawnNCT06329830
What this trial is testing

177Lu-PSMA, Niraparib/AA Plus Prednisone for Prostate Cancer

Who this might be right for
Metastatic Prostate CancerCastration-resistant Prostate CancerMetastatic Castration-resistant Prostate Cancer
Baptist Health South Florida
Not applicableStudy completedNCT03867357
What this trial is testing

Intramuscular Mechanisms of Androgen Deprivation-related Sarcopenia

Who this might be right for
Metastatic Prostate CancerAndrogen Deprivation Therapy
Seattle Institute for Biomedical and Clinical Research 60
Testing effectiveness (Phase 2)Study completedNCT07333976
What this trial is testing

O Tadalafil for Prevention of Docetaxel-Induced Peripheral Neuropathy in Prostate Cancer

Who this might be right for
Prostate Cancer Metastatic DiseaseChemotherapy Induced Peripheral Neuropathy (CIPN)Neurotoxicity
Tri-Service General Hospital (TSGH) 90
Large-scale testing (Phase 3)Study completedNCT02981368
What this trial is testing

Study of 18F-DCFPyL PET/CT Imaging in Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Progenics Pharmaceuticals, Inc. 385
Next Page